Changjian Shao

2PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Oct 28, 2024
Perioperative sintilimab and neoadjuvant anlotinib plus chemotherapy for resectable non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 2 trial (TD-NeoFOUR trial).

Hongtao Duan, Changjian Shao, Zhilin Luo

|Jun 06, 2022
Melatonin may suppress lung adenocarcinoma progression via regulation of the circular noncoding RNA hsa_circ_0017109/miR-135b-3p/TOX3 axis.

Yuanyong Wang, Zhaoyang Wang, Changjian Shao

Pageof 1

Frequent Collaborators

2 joint publications

Xiaolong Yan

1 joint publications

Yuanyong Wang

1 joint publications

Zhaoyang Wang

1 joint publications

Guofang Lu